Combined with previous finding and the results presented in our study, we believe that SELENBP1 reduced in ER+ cells might due to high estrogen levels, and that neutralizing the effect of estrogen in down-regulating SELENBP1 expression can enhance the function of selenium in cancer prevention and treatment. This evidence concerns the gene SELENBP1 and cancer.